AT-Biotech
Automated traceability solutions for the healthcare industry.
Isolation Sciences LLC
Side-by-Side Comparison
| Metric | AT-Biotech | Isolation Sciences LLC |
|---|---|---|
| Founded | 2009 | 2006 |
| Headquarters | Madrid, Spain | United States |
| Employees | 9 | 3 |
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Manufacturing, Pharmaceutical |
| Funding Stage | Series Unknown | Seed |
| Total Funding | Not tracked yet | $212.00K |
| Funding Rounds | 1 | 3 |
| Business Model | Not tracked yet | Not tracked yet |
| Revenue Model | Not tracked yet | Not tracked yet |
| Services | Not tracked yet | Not tracked yet |
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | Safety, Traceability, RFID, Pharmaceuticals, Biological Samples, Tissues, Organs, Technology, Hardware, Patient Safety | Biological Containment, Chemical Containment, Medical Isolation, Mass Casualty Events, Pharmaceutical Research, Laboratory Energy Reduction, Fume Hoods, Biological Safety Cabinets, Hazardous Material Remediation, Flexible Isolation Barrier Film, Continuous Access Port, Innovation, Technology Platform, Environmental Safety |
| Website | at-biotech.com | isolationsciences.com |
About AT-Biotech
AT-Biotech is a Spanish biotech startup founded in 2009 that offers automated traceability solutions for the healthcare industry. Specializing in processes involving biological and pharmacological products, AT-Biotech's solutions prioritize patient safety, professional comfort and calmness, and oper...
About Isolation Sciences LLC
Isolation Sciences LLC, established in 2006 and headquartered in the United States, focuses on developing innovative solutions for containing hazardous biological and chemical aerosols. The company's expertise lies in medical isolation and mass casualty emergency events, pharmaceutical industry rese...
Frequently Asked Questions
Track both companies in real time
Signal Tracker monitors AT-Biotech, Isolation Sciences LLC, and millions of companies for 40+ signal types.